Pharmaceutical Supply, Pharmaceutical Manufacturing, Contract Research, Pharmaceutical Outsourcing

Headlines

(FatCamera/iStock via Getty Images Plus)

Phesi analysis highlights extent of cancer trial inclusion issues

The latest indepth report from the AI-centric analytics provider reveals nearly half of US cancer clinical studies enroll no Latino patient participants.

(Andrew Brookes/iStock via Getty Images Plus)

Sema4, Avera Health partner on precision cancer care initiative

The health care system and analytics company are joining on the ASAP study, a program that constitutes a five-year commitment to advancing cancer solutions.

Decentralized clinical trial transformations are ‘here to stay’: ICON

In this first of a two-part series, an expert discusses various factors behind the DCT format’s rapid rise and likely longevity in the drug development arena.

(Callista Images/iStock via Getty Images Plus)

Eli Lilly gets speedy NICE recommendation for breast cancer treatment

England's cost-effectiveness watchdog has recommended Eli Lilly’s Verzenios treatment as an option for adjuvant treatment of certain forms of breast cancer.

Indiana University Health enlists LifeOmic platform for cancer research

The academic research center has adopted the life science technology company’s cloud-based platform for cancer research, drug discovery, and clinical trials.